Specialist Area: Urology and Uro-Oncology

Dr Eapen is undertaking a PhD, studying the use of a novel radionuclide agent, Lutetium PSMA in high risk prostate cancer. Her translational research will investigate how giving Lutetium PSMA before surgery in prostate cancer can alter the immune microenvironment of the tumour to reduce the risk of recurrence and improve long term survival.  She sits … Continued

  Declan is an independent specialist practitioner who provides his services from the Cancer Specialists premises.